Immunological aspects of cancer chemotherapy

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399

Calreticulin exposure dictates the immunogenicity of cancer cell death

Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473

A cytokine-mediated link between innate immunity, inflammation, and cancer

Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U. S., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,625

Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer

Marín‐Aguilera, M., Jiménez, N., Reig, Ò., Montalbo, R., Verma, A. K., Castellano, G., Mengual, L., Victoria, I., Pereira, M. V., Milà‐Guasch, M., et al. (2020) · Cells · doi:10.3390/cells9010203 · Cited by 25

Emerging Immunotherapy Strategies in Breast Cancer

Page, D. B., Naidoo, J., & McArthur, H. L. (2014) · Immunotherapy · doi:10.2217/imt.13.166 · Cited by 24

Challenging the recalcitrant disease—developing molecularly driven treatments for small cell lung cancer

Mak, D. W.-S., Su, L., & Minchom, A. R. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.037 · Cited by 24

Fumagillin Attenuates Spinal Angiogenesis, Neuroinflammation, and Pain in Neuropathic Rats after Chronic Constriction Injury

Wen, Z., Huang, S., Kuo, H., Chen, C.-T., Chen, N., Chen, W.-F., Tsui, K., Liu, H., & Sung, C. (2021) · Biomedicines · doi:10.3390/biomedicines9091187 · Cited by 24

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies

Atkins, M. B., Ascierto, P. A., Feltquate, D., Gulley, J. L., Johnson, D. B., Khushalani, N. I., Sosman, J. A., Yap, T. A., Kluger, H. M., Sullivan, R. J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005923 · Cited by 26

Redox-regulating nanotherapeutics potentiating ferroptosis-driven cancer treatment

Yang, X., Sun, X., Lei, J., Shi, X., Zhang, S., & Luo, C. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149518 · Cited by 24

Gemcitabine chemotherapy induces phenotypic alterations of tumor cells that facilitate antitumor T cell responses in a mouse model of oral cancer

Tomihara, K., Fuse, H., Heshiki, W., Takei, R., Zhang, B., Arai, N., Nakamori, K., & Noguchi, M. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.013 · Cited by 25

Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis

Alex, A. A., Ganesan, S., Palani, H. K., Balasundaram, N., David, S., Lakshmi, K. M., Kulkarni, U. P., Nisham, P. N., Korula, A., Devasia, A. J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01357 · Cited by 24

Screening of toxoplasmosis in cancer patients: a concern

Abdoli, A., Barati, M., Pirestani, M., & Dalimi, A. (2018) · Tropical Doctor · doi:10.1177/0049475518801618 · Cited by 24

Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination

Mukherjee, S., Chakraborty, S., Basak, U., Pati, S., Dutta, A., Dutta, S., Roy, D., Banerjee, S., Ray, A., Sa, G., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00787-z · Cited by 23

Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy

Liu, J., Li, B., Li, L., Ming, X., & Xu, Z. P. (2024) · Small · doi:10.1002/smll.202403024 · Cited by 23

Prostate cancer vaccines: the long road to clinical application

Baxevanis, C. N., Papamichail, M., & Perez, S. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1667-7 · Cited by 23

Role of Immunotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer

Rijavec, E., Genova, C., Alama, A., Barletta, G., Sini, C., Pronzato, P., Coco, S., Bello, M. G. D., Savarino, G., Truini, A., et al. (2013) · Future Oncology · doi:10.2217/fon.13.145 · Cited by 23

Type of chemotherapy has substantial effects on the immune system in ovarian cancer

Vankerckhoven, A., Baert, T., Riva, M., Bruyn, C. D., Thirion, G., Vandenbrande, K., Ceusters, J., Vergote, I. B., & Coosemans, A. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101076 · Cited by 23

Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy

Japir, A. A.-W. M. M., Ke, W., Li, J., Mukerabigwi, J. F., Ibrahim, A., Wang, Y., Li, X., Zhou, Q., Mohammed, F., & Ge, Z. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.015 · Cited by 23

Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy

Mao, X., Calero‐Pérez, P., Montpeyó, D., Bruna, J., Yuste, V. J., Candiota, A. P., Lorenzo, J., Novio, F., & Ruiz‐Molina, D. (2022) · Nanomaterials · doi:10.3390/nano12071221 · Cited by 24

Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers

Gazińska, P., Milton, C. K., Iacovacci, J., Ward, J. A., Buus, R., Alaguthurai, T., Graham, R. A., Akarca, A. U., Lips, E. H., Naidoo, K., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0543 · Cited by 23

Nanotheranostic Strategies for Cancer Immunotherapy

Nguyen, A., Kumar, S., & Kulkarni, A. A. (2022) · Small Methods · doi:10.1002/smtd.202200718 · Cited by 24

Ablation of p57+ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

Oka, T., Higa, T., Sugahara, O., Koga, D., Nakayama, S., & Nakayama, K. I. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2578 · Cited by 23

In situ vaccination via tissue-targeted cDC1 expansion enhances the immunogenicity of chemoradiation and immunotherapy

Lam, B. K., Kung, Y. J., Lin, J. C., Tseng, S.-H., Tu, H.-F., Huang, C. Y. ‐., Lee, B., Velarde, E., Tsai, Y. C., Villasmil, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171621 · Cited by 23

Chitosan‐coated nanoparticles in innovative cancer bio‐medicine

Rezaei, N., Zarkesh, I., Fotouhi, A., Alikhani, H. K., Hassan, M., & Vosough, M. (2024) · Drug Development Research · doi:10.1002/ddr.22189 · Cited by 24

Chromatin as an old and new anticancer target

Neefjes, J., Gurova, K. V., Sarthy, J. F., Szabó, G., & Henikoff, S. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.05.005 · Cited by 23

Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy

Rigamonti, N., & Bellone, M. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1216-6 · Cited by 24

The significance and therapeutic potential of PD-1 and its ligands in ovarian cancer: A systematic review

Zhu, X., & Lang, J. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.04.002 · Cited by 23

Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies

Torchia, J. A., Weiskopf, K., & Levy, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603335113 · Cited by 23

Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model

Karageorgis, A., Claron, M., Jugé, R., Aspord, C., Thoreau, F., Leloup, C., Kucharczak, J., Plumas, J., Henry, M., Hurbin, A., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.002 · Cited by 25

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients

Sampath, S., Won, H., Massarelli, E., Li, M., Frankel, P. H., Vora, N. L., Vora, L., Maghami, E. G., & Kortylewski, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24397 · Cited by 23

Melanization as unfavorable factor in amelanotic melanoma cell biology

Skoniecka, A., Cichorek, M., Tymińska, A., Pelikant‐Małecka, I., & Dziewíatkowski, J. (2021) · PROTOPLASMA · doi:10.1007/s00709-021-01613-5 · Cited by 23

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

Marmé, F., Werft, W., Walter, A., Keller, S., Wang, X., Benner, A., Burwinkel, B., Sinn, H., Hug, S., Sohn, C., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1759-9 · Cited by 23

Use of Anti-Cancer Drugs, Mitocans, to Enhance the Immune Responses against Tumors

Hahn, T., Polanczyk, M. J., Borodovsky, A., Ramanathapuram, L. V., Akporiaye, E. T., & Ralph, S. J. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030010 · Cited by 22

Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer

Lee, N. K., Choi, J. U., Kim, H. R., Chung, S. W., Ko, Y. G., Cho, Y. S., Park, S. J., Lee, E. J., Kim, S. Y., Kim, I., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121105 · Cited by 23

Leveraging tumor cell ferroptosis for colorectal cancer treatment via nanoelicitor-activated tumoricidal immunity

Chen, C., Du, W., Jing, W., Sun, P., Shi, C., Zhang, S., Liu, Y., Cui, P. Y., Li, A., Zhang, R., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.132983 · Cited by 22

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines

Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler‐Hoffmann, M., Ricciardelli, C., Oehler, M. K., Blencowe, A., Garg, S., & Albrecht, H. (2022) · Cancers · doi:10.3390/cancers14102362 · Cited by 24

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients

van der Sijde, F., Dik, W. A., Mustafa, D. A. M., Vietsch, E. E., Besselink, M. G., Debets, R., Koerkamp, B. G., Haberkorn, B. C. M., Homs, M. Y. V., Janssen, Q. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898498 · Cited by 23

Bacterial Infections among Patients with Chronic Diseases at a Tertiary Care Hospital in Saudi Arabia

Bazaid, A. S., Punjabi, A. A., Aldarhami, A., Qanash, H., Alsaif, G., Gattan, H. S., Barnawi, H., Alharbi, B., Alrashidi, A., & Alqadi, A. (2022) · Microorganisms · doi:10.3390/microorganisms10101907 · Cited by 21

Flavonoids for the Treatment of Breast Cancer, Present Status and Future Prospective

Sahoo, S. K., Sahoo, S., & Mohapatra, P. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666221024114521 · Cited by 25

From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential

Mignini, I., Piccirilli, G., Galasso, L., Termite, F., Esposto, G., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020420 · Cited by 25

The p50 Subunit of NF-κB Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity

Larghi, P., Porta, C., Riboldi, E., Totaro, M. G., Carraro, L., Orabona, C., & Sica, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045279 · Cited by 22

Current Strategies in Immunotherapy for Acute Myeloid Leukemia

Lichtenegger, F. S., Schnorfeil, F. M., Hiddemann, W., & Subklewe, M. S. (2012) · Immunotherapy · doi:10.2217/imt.12.145 · Cited by 22

From the Hellstrom paradox toward cancer cure

Hellström, K. E., & Hellström, I. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.11.002 · Cited by 22

Dual-targeted therapeutic strategy combining CSC–DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model

El‐Ashmawy, N. E., Salem, M. L., Khedr, E. G., El-Zamarany, E., & Ibrahim, A. O. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02242-4 · Cited by 23

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

Arribillaga, L., Echeverria, I., Belsúe, V., Gomez, T., Lozano, T., Casares, N., Villanueva, L., Domingos‐Pereira, S., Romero, P. J., Nardelli‐Haefliger, D., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000704 · Cited by 24

Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice

Katō, Y., Zhu, W., Backer, M. V., Neoh, C. C., Hapuarachchige, S., Sarkar, S. K., Backer, J. M., & Artemov, D. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1736-9 · Cited by 23

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell‐Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

Ridolfi, L., Petrini, M., Fiammenghi, L., Granato, A. M., Ancarani, V., Pancisi, E., Scarpi, E., Guidoboni, M., Migliori, G., Sanna, S., et al. (2010) · Journal of Immunology Research · doi:10.1155/2010/504979 · Cited by 22

Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles

Zheng, C., Zhang, W., Gong, X., Xiong, F., Jiang, L., Zhou, L., Zhang, Y. E., Zhu, H. H., Wang, H., Li, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk9996 · Cited by 21

Interactions between the tumor microbiota and breast cancer

Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 22

Engineering combination nanomedicines to overcome cancer resistance

Singh, H., Balusamy, S. R., Sukweenadhi, J., Shrivastav, A., Mohanprasanth, A., Saravanan, M., Mijakovic̀, I., & Singh, P. (2026) · RSC Advances · doi:10.1039/d5ra08728g · Cited by 23

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma

Batich, K. A., Swartz, A. M., & Sampson, J. H. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.972361 · Cited by 21

Constructing Hypoxia‐Tolerant and Host Tumor‐Enriched Aggregation‐Induced Emission Photosensitizer for Suppressing Malignant Tumors Relapse and Metastasis

Cui, S., Dai, S., Lin, N., Wu, X., Shi, J., Tong, B., Liu, P., Cai, Z., & Dong, Y. (2022) · Small · doi:10.1002/smll.202203825 · Cited by 20

Effects of metabolic cancer therapy on tumor microenvironment

Hyroššová, P., Milošević, M., Škoda, J., Vachtenheim, J., Jr., Rohlena, J., & Rohlenová, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1046630 · Cited by 23

Impact of microbiota on breast cancer hormone therapy

Terrisse, S. A., Zitvogel, L., & Kroemer, G. (2023) · Cell Stress · doi:10.15698/cst2023.03.277 · Cited by 22

Nanoplatforms: The future of oral cancer treatment

Senevirathna, K., Jayawickrama, S. M., Jayasinghe, Y. A., Prabani, K. I. P., Akshala, K., Pradeep, R., Damayanthi, H. D. W. T., Hettiarachchi, P. V. K. S., Dorji, T., Lucero‐Prisno, D. E., et al. (2023) · Health Science Reports · doi:10.1002/hsr2.1471 · Cited by 21

Biomarkers and experimental models for cancer immunology investigation

Xu, H., Jia, Z., Liu, F., Li, J., Huang, Y., Jiang, Y., Pu, P., Shang, T., Tang, P., Zhou, Y., et al. (2023) · MedComm · doi:10.1002/mco2.437 · Cited by 21

Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence

Kirti, A., Simnani, F. Z., Jena, S., Lenka, S. S., Kalalpitiya, C., Naser, S. S., Singh, D., Choudhury, A., Sahu, R. N., Yadav, A., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216990 · Cited by 21

Synergistic Anticancer Effects of Pam3CSK4 and Ara-C on B-Cell Lymphoma Cells

Lee, S.-K., Chwee, J. Y., Ma, C. A. P., Bert, N. L., Huang, C. W., & Gasser, S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2522 · Cited by 21

Dendritic cell-based cancer vaccination:quo vadis?

Dauer, M., Schnurr, M., & Eigler, A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1041 · Cited by 21

Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer

Korpanty, G. J., & Smyth, E. C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626166 · Cited by 21

Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity

Cantini, G., Pisati, F., Pessina, S., Finocchiaro, G., & Pellegatta, S. (2012) · OncoImmunology · doi:10.4161/onci.20637 · Cited by 21

Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737

Sutton, V. R., Sedelies, K. A., Dewson, G., Christensen, M. E., Bird, P. I., Johnstone, R. W., Kluck, R. M., Trapani, J. A., & Waterhouse, N. J. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.73 · Cited by 21

Algorithm for Designing Nanoscale Supramolecular Therapeutics with Increased Anticancer Efficacy

Kulkarni, A. A., Pandey, P. R., Rao, P., Mahmoud, A., Goldman, A. J., Sabbisetti, V. S., Parcha, S., Natarajan, S. K., Chandrasekar, V., Dinulescu, D. M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b00241 · Cited by 21

Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology

Bencze, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010362 · Cited by 20

Checkpoint Modulation in Melanoma: An Update on Ipilimumab and Future Directions

Page, D. B., Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0337-1 · Cited by 22

One‐Step Method for Instant Generation of Advanced Allogeneic NK Cells

Lee, D. Y., Lim, K. S., Valencia, G. M., Jung, M., Bull, D. A., & Won, Y.-W. (2018) · Advanced Science · doi:10.1002/advs.201800447 · Cited by 19

Exercise training as prophylactic strategy in the management of neutropenia during chemotherapy

Schauer, T., Højman, P., Gehl, J., & Christensen, J. F. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15141 · Cited by 22

Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer

Pangeni, R., Subedi, L., Jha, S. K., Kweon, S., Kang, S.-H., Chang, K.-Y., Choi, J. U., Byun, Y., & Park, J. W. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s267424 · Cited by 22

Role of innate immunity in chemotherapy-induced peripheral neuropathy

Uhelski, M. L., Li, Y., Fonseca, M. M., Romero-Sandoval, E. A., & Dougherty, P. M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135941 · Cited by 19

Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6

Klepsch, V., Siegmund, K., & Baier, G. (2021) · Cancers · doi:10.3390/cancers13112600 · Cited by 21

Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model

Le, T., Su, S., & Shahriyari, L. (2021) · Cells · doi:10.3390/cells10082009 · Cited by 22

Metabolic Modifications, Inflammation, and Cancer Immunotherapy

Zheng, S., Song, Q., & Zhang, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.703681 · Cited by 19

A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner

El-Sayes, N., Vito, A., Salem, O., Workenhe, S. T., Wan, Y., & Mossman, K. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031754 · Cited by 20

Combination of ovalbumin-coated iron oxide nanoparticles and poly(amidoamine) dendrimer-cisplatin nanocomplex for enhanced anticancer efficacy

Mekonnen, T. W., Darge, H. F., Tsai, H., Birhan, Y. S., Hanurry, E. Y., Gebrie, H. T., Chou, H., Lai, J., Lin, S., Harn, H., et al. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112391 · Cited by 20

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry

Cortellini, A., Gennari, A., Pommeret, F., Patel, G., Newsom-Davis, T. E., Bertuzzi, A. F., Viladot, M., Mirallas, O., Felip, E., Lee, A. J. X., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac057 · Cited by 20

NIR-Active Porphyrin-Decorated Lipid Microbubbles for Enhanced Therapeutic Activity Enabled by Photodynamic Effect and Ultrasound in 3D Tumor Models of Breast Cancer Cell Line and Zebrafish Larvae

Guduru, A. T., Manav, N., Mansuri, A., Gupta, I., Bhatia, D. D., Kumar, A., & Dalvi, S. V. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00483 · Cited by 20

The Anti-Tumor and Immunomodulatory Effects of PLGA-Based Docetaxel Nanoparticles in Lung Cancer: The Potential Involvement of Necroptotic Cell Death through Reactive Oxygen Species and Calcium Build-Up

Gupta, P., Singh, A., Verma, A. K., Kant, S., Pandey, A. K., Khare, P., & Prakash, V. (2022) · Vaccines · doi:10.3390/vaccines10111801 · Cited by 20

Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives

Panthi, V. K., Dua, K., Singh, S. K., Gupta, G., Hansbro, P. M., & Paudel, K. R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041192 · Cited by 20

Cyclophosphamide in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Barnes, H., Ghazipura, M., Herman, D. D., Macrea, M. M., Knight, S. L., Silver, R. M., Montesi, S. B., Raghu, G., & Hossain, T. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202301-053oc · Cited by 21

Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade

Yu, Y., Zhang, F., Xiao, W., Cheng, Q., Li, T., Tang, J., Tao, W., & Mei, L. (2024) · ACS Nano · doi:10.1021/acsnano.3c13056 · Cited by 20

Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer

Wang, Y., Pattarayan, D., Huang, H., Zhao, Y., Li, S., Wang, Y., Zhang, M., Li, S., & Yang, D. (2024) · Nature Communications · doi:10.1038/s41467-024-47433-y · Cited by 20

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

Abdel-Fatah, T. M. A., McArdle, S. E. B., Agarwal, D., Moseley, P. M., Green, A. R., Ball, G. R., Pockley, A. G., Ellis, I. O., Rees, R. C., & Chan, S. Y. T. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0610 · Cited by 20

Current status of immunotherapy for the treatment of biliary tract cancer

Takahashi, R., Yoshitomi, M., Yutani, S., Shirahama, T., Noguchi, M., Yamada, A., Itoh, K., & Sasada, T. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23844 · Cited by 20

Greater than the sum of their parts: Combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation

Dudakov, J. A., & van den Brink, M. R. M. (2011) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2011.05.003 · Cited by 20

An Autologous In Situ Tumor Vaccination Approach for Hepatocellular Carcinoma. 2. Tumor-Specific Immunity and Cure after Radio-Inducible Suicide Gene Therapy and Systemic CD40-Ligand and Flt3-Ligand Gene Therapy in an Orthotopic Tumor Model

Kawashita, Y., Deb, N. J., Garg, M. K., Kabarriti, R., Fan, Z., Alfieri, A. A., Roy‐Chowdhury, J., & Guha, C. (2014) · Radiation Research · doi:10.1667/rr13617.1 · Cited by 20

Immune classification of colorectal cancer patients: impressive but how complete?

Baxevanis, C. N., Papamichail, M., & Perez, S. A. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.751971 · Cited by 20

Metronomic chemotherapy and nanocarrier platforms

Lila, A. S. A., & Ishida, T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.007 · Cited by 20

Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders

Phillips, T. J., Devata, S., & Wilcox, R. A. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0201-6 · Cited by 21

Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival

Schlotter, C. M., Tietze, L., Vogt, U., Heinsen, C. V., & Hahn, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0022 · Cited by 20

Smart pH-responsive nanoparticles in a model tumor microenvironment for enhanced cellular uptake

Pan, J., Lei, S., Chang, L., & Wan, D. (2018) · Journal of Materials Science · doi:10.1007/s10853-018-2931-y · Cited by 21

HSF1 phosphorylation by cyclosporin A confers hyperthermia sensitivity through suppression of HSP expression

Shao, J., Han, B., Cao, P., Zhang, B., Liu, M., Li, D., Zhou, N., Hao, Q., Duan, X., Chang, Y., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.04.009 · Cited by 20

Macrophage polarization by phytotherapy in the tumor microenvironment

Saeedifar, A. M., Mosayebi, G., Ghazavi, A., Bushehri, R. H., & Ganji, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7058 · Cited by 19

A Combination of Alkaloids and Triterpenes of Alstonia scholaris (Linn.) R. Br. Leaves Enhances Immunomodulatory Activity in C57BL/6 Mice and Induces Apoptosis in the A549 Cell Line

Feng, L., Chen, Y., Yuan, L., Liu, X., Gu, J., Zhang, M., & Wang, Y. (2013) · Molecules · doi:10.3390/molecules181113920 · Cited by 20

Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy

Denkert, C., Darb‐Esfahani, S., Loibl, S., Anagnostopoulos, I., & Jöhrens, K. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0261-0 · Cited by 20

Radiotherapy in patients with HIV: current issues and review of the literature

Alongi, F., Giaj‐Levra, N., Sciascia, S., Fozza, A., Fersino, S., Fiorentino, A., Mazzola, R., Ricchetti, F., Buglione, M., Buonfrate, D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30440-0 · Cited by 20

Correction: Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response

Yu, J., He, X., Wang, Z., Wang, Y., Liu, S., Xie, Z., Li, X., & Huang, Y. (2021) · Nanoscale · doi:10.1039/d1nr90174e · Cited by 20

Traditional Oriental Herbal Medicine and Natural Killer Cells for Cancer Patients: A Systematic Review and Meta-analysis

Bae, K., Park, J.-H., Kim, J., Cho, C.-K., Oh, B., Costa, D. S. J., Lim, S. H.-S., Deng, G. E., & Yoo, H.-S. (2017) · Phytotherapy Research · doi:10.1002/ptr.5781 · Cited by 19

Immunization with cell‐free‐generated vaccine protects from Porphyromonas gingivalis‐induced alveolar bone loss

Huang, N., Shimomura, E., Yin, G., Tran, C., Sato, A. K., Steiner, A., Heibeck, T. H., Tam, M., Fairman, J., & Gibson, F. C. (2018) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13047 · Cited by 19

Immune checkpoint inhibition for the treatment of mesothelioma

Nowak, A. K., McDonnell, A. M., & Cook, A. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1606209 · Cited by 20

Recombinant Lactaptin Induces Immunogenic Cell Death and Creates an Antitumor Vaccination Effect in Vivo with Enhancement by an IDO Inhibitor

Troitskaya, O. S., Varlamov, M., Nushtaeva, A. A., Richter, V. A., & Koval, O. A. (2020) · Molecules · doi:10.3390/molecules25122804 · Cited by 19

Interplay between the DNA Damage Response and Immunotherapy Response in Cancer

Lee, E. C. Y., Kok, J. S.-T., Teh, B. T., & Lim, K. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113356 · Cited by 22

Chromomycin A5 induces bona fide immunogenic cell death in melanoma

Florêncio, K. G. D., Edson, E. A., Fernandes, K. S. D. S., Luiz, J. P. M., Pinto, F. D. C. L., Pessoa, O. D. L., Cunha, F. Q., Machado‐Neto, J. A., & Wilke, D. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941757 · Cited by 20

Nanomedicine Targeting Myeloid‐Derived Suppressor Cells Enhances Anti‐Tumor Immunity

Yang, E., & Sun, Z. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303294 · Cited by 19

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

Bracci, L., Schiavoni, G., Sistigu, A., & Belardelli, F. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.67 · Cited by 951

Immune Effects of Conventional Cancer Therapeutics

Demaria, S., & Galluzzi, L. (2018) · Springer Publishing Company eBooks · doi:10.1891/9781617052736.0022

Activation of Immune-Mediated Tumor Cell Death by Chemotherapy

McCoy, M. J., Nowak, A. K., & Lake, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5847-0_14

Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy

Hannani, D., Sistigu, A., Kepp, O., Galluzzi, L., Kroemer, G., & Zitvogel, L. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182325d4d · Cited by 88

Immunogenic effects of chemotherapy-induced tumor cell death

Wang, Y., Fletcher, R., Yu, J., & Zhang, L. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.003 · Cited by 328